WeightlessRx vs Ro

How WeightlessRx and Ro Body compare on medication, pricing, support, and care model.

Last updated: May 4, 2026 Reviewed against: Current obesity-medicine and GLP-1 treatment guidelines Category: Comparison

At a glance

FeatureWeightlessRxRo Body
Medications offeredCompounded sema, compounded tirzBrand-name (when available) and compounded sema/tirz
Membership feeNone$145/month
Included GLP-1 fitness appYesYes
1-on-1 nutrition coachingIncludedLimited
Direct clinician messagingUnlimitedAvailable
HSA / FSA eligibleYesYes
Free shippingYesYes

Medication options

Ro markets brand-name Wegovy and Zepbound when available, plus compounded sema/tirz. WeightlessRx focuses on compounded sema and tirz with consistent supply through licensed U.S. compounding pharmacies.

Pricing structure

Ro Body charges $145/month for the program subscription on top of medication cost. WeightlessRx has no separate program fee — you pay for medication. Over 12 months, that is approximately $1,740 in additional Ro membership cost.

Support model

Both programs offer clinician messaging and digital tools. WeightlessRx includes 1-on-1 nutrition coaching and personalized meal plans by default; Ro’s coaching is more limited.

Who each is best for

Frequently asked questions

Can I get the same active ingredient at WeightlessRx?
Yes. WeightlessRx offers compounded versions of the same active ingredients (semaglutide and tirzepatide) used in branded GLP-1 products.
Is WeightlessRx cheaper than Ro?
For most members, yes — primarily because there is no monthly membership fee on top of the medication.

Ready when you are.

Take a 90-second medical intake. Your clinician reviews it and prescribes only when clinically appropriate.

See treatment plans →

Related reading

Editorial standards & medical oversight

This educational content follows WeightlessRx clinical content standards and is reviewed for accuracy against current obesity-medicine and GLP-1 treatment guidelines, including FDA prescribing information, the American Association of Clinical Endocrinology (AACE) obesity guideline, and peer-reviewed clinical literature. Information is educational and is not medical advice. Treatment eligibility is determined only after a U.S.-licensed clinician in our third-party provider network reviews your intake and medical history. Read our full medical review policy →